Zynex (ZYXI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today is proud to announce that two of our executives have been featured among Medical Technology's Top 25 by The Healthcare Technology Report. This prestigious recognition highlights the quality and depth of talent within Zynex.
Zynex, Inc. (NASDAQ:ZYXI) Q1 2024 Earnings Call Transcript April 30, 2024 Zynex, Inc. beats earnings expectations. Reported EPS is $0.0003, expectations were $. ZYXI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen. And welcome to the […]